The Lupus Anticoagulant (LA) test in citrated plasma is an important tool for evaluating risks associated with clotting disorders. This test is conducted to detect the presence of antibodies that affect the clotting process, which may increase the risk of blood clots or lead to conditions such as deep vein thrombosis or strokes. A sample of citrated plasma, a type of plasma containing an anticoagulant substance, is drawn and then analyzed using specific techniques to detect lupus anticoagulant. The presence of these antibodies is an indicator of conditions such as antiphospholipid syndrome or autoimmune diseases. The results of this test help doctors assess the risk of blood clotting and guide appropriate treatment options for patients, contributing to better healthcare and prevention of complications